Dow Up 0.07% Nasdaq Up 0.61%

Novo Nordisk A/S (NVO)

-NYSE
44.93 Up 0.26(0.58%) Nov 26, 4:03PM EST
Prev Close:44.67
Open:44.67
Bid:43.65 x 1000
Ask:46.00 x 100
1y Target Est:49.37
Beta:0.89
Next Earnings Date:N/A
Day's Range:44.63 - 45.00
52wk Range:34.81 - 49.11
Volume:723,072
Avg Vol (3m):1,460,250
Market Cap:117.44B
P/E (ttm):27.36
EPS (ttm):1.64
Div & Yield:0.61 (1.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVOUp 0.58%117.44B
LLYUp 0.70%72.01B
PFEUp 2.07%195.95B
SNYUp 0.92%126.20B

Key Statistics

Forward P/E (1 yr):22.69
P/S (ttm):8.13
Ex-Dividend Date:21-Mar-14

Analysts

Annual EPS Est (Dec-14) :1.73
Quarterly EPS Est (Jun-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback